News by Topic
News Archive
Drug Alerts
Recently Added
Top 10 Pages

News - January 2010

A woman in Potter County, Texas, has sued Botox manufacturer Allergan Inc., claiming that Botox injections (botulinum toxin type A) led to her 7-year-old daughter Kristen’s death in November 2007, just 15 months after she began treatment with Botox...

Women being treated with certain antidepressants may have delayed lactation when they become new mothers, according to a new study set to be published in the Journal of Clinical Endocrinology & Metabolism.

According to a study published in the Journal of General Internal Medicine, older adults who take potent prescription painkillers known as opioids are at an increased risk of bone fractures.

The study examined more than 2,300 adults aged 60 or older who experienced chronic pain....

On January 21, 2010, the U.S. Food and Drug Administration (FDA) issued an additional contraindication for sibutramine, marketed as the weight loss medication Meridia, following the review of study data from the SCOUT (Sibutramine Cardiovascular OUTcomes)...

The U.S. Food and Drug Administration approved Ampyra, a new medication intended to improve walking ability in individuals with multiple sclerosis, on January 22, 2010. In clinical trials, patients who took Ampyra illustrated a marked improvement in walking speed in comparison with individuals...

As designated by the United States Congress, January is Cervical Health Awareness Month, intended to increase awareness and ultimately aid in the prevention and early detection of cervical cancer.

According to the National Cancer Institute, in 2009, more than 4,000 women died from...

A new study suggests a possible link between long-term use of oral contraceptives and a decrease in bone density in women under the age of 30. Researchers studied more than 600 women, aged 14 to 30, and found a 5.9 percent decrease in bone mineral density (BMD) of the spine in young women taking...

A woman filed a lawsuit against Bayer HealthCare, the manufacturer of Yaz birth control, after she experienced a stroke and other serious side effects while taking Ocella, a generic version of the oral contraceptive.

The U.S. Food and Drug Administration (FDA) issued a warning for consumers on January 18, 2010, concerning their discovery of a potentially harmful counterfeit version of GlaxoSmithKline’s Alli 60 mg capsules in a 120-count refill kit.

The counterfeit Alli contains sibutramine instead of...

Less than a month after the recall of Tylenol Arthritis Pain Caplets due to a moldy smell that made some people sick, Johnson & Johnson has issued a massive recall that includes additional medications due...

According to the National Cancer Institute, several studies have revealed a link between the use of oral contraceptives and an increased risk of certain types of cancer, including breast cancer, cervical cancer, and liver cancer. The connection between the development of some cancers and...

On January, 13, 2010, Merck & Co. announced that it has submitted new trial data to the U.S. Food and Drug Administration (FDA) regarding the Gardasil vaccine and its expanded use in women aged 27 to 45. Previously approved for use in girls and women...

According to a study published by the British Medical Journal (BMJ) on January 12, 2010, patients taking certain blood pressure medications appear to experience a reduced risk of developing dementia, a condition commonly associated with memory loss and Alzheimer’s disease.

The U.S. Food and Drug Administration (FDA) approved Actemra (tocilizumab) on January 8, 2010, for use in patients with cases of moderate to severe rheumatoid arthritis (RA) who have not responded to treatment with methotrexate or other second...

The U.S. Food and Drug Administration (FDA) recommended against the approval of high blood pressure medication Bystolic for the treatment of patients suffering from heart failure.

Bystolic was approved for the treatment of high...

Qnexa, a drug currently undergoing testing for its ability to aid in weight loss, reduced the incidence of sleep apnea by 69 percent in those taking the medication as part of a small-scale trial.

The anti-obesity drug, developed by Vivus Inc., was examined in a 28-week phase II trial...

A study published in the January 6, 2010 issue of The Journal of the American Medical Association (JAMA) concluded that patients with severe depression may benefit the most from antidepressant medications.

According to a review of the study on JAMA’s Web site, the study was conducted “to...

A product called “Nzu,” used traditionally as a remedy for morning sickness, has been found to contain high levels of lead and arsenic, according to a recent review by the Texas Department of State Health Services (DSHS).

On December 31, 2009, the U.S. Food and Drug Administration (FDA)...

The experimental diabetes drug balaglitazone, under development by Dr. Reddy’s Laboratories, has hit its primary target in recent late-stage clinical trials, successfully lowering blood glucose levels in patients with type 2 diabetes, with less weight gain and water retention than seen with...

Drug News & Alerts
Subscribe to RSS